However, since semaglutide impacts gastric emptying, the dosage of any other drugs taken concomitantly should be appropriately monitored by health care providers
FOXO4-DRI Regulatory Status As of June 2026, FOXO4-DRI is not approved by the FDA or any other regulatory agency for human use
Cagrilintide is a long-acting amylin analogue it mimics a hormone that regulates appetite and slows gastric emptying
on orders over $40 Subscribe and save 10% Take 10% off with code INNERBODY Cons Potentially much higher absorption rate means a less studied (and more unpredictable) effective dosage Expensive compared to alternatives Known mostly for its excellent NAD+ supplements, Renue By Science steps out of its usual arena with LIPO Berberine
Alternative medications beyond switching back to tirzepatide deserve consideration
Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) BPC157 Overview and How It Works BPC157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice
